tiprankstipranks
Trending News
More News >
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY
Advertisement

Sinopharm Group Co (SHTDY) Price & Analysis

Compare
21 Followers

SHTDY Stock Chart & Stats

$12.04
-$0.11(-0.80%)
At close: 4:00 PM EST
$12.04
-$0.11(-0.80%)

SHTDY FAQ

What was Sinopharm Group Co’s price range in the past 12 months?
Sinopharm Group Co lowest stock price was $11.02 and its highest was $14.24 in the past 12 months.
    What is Sinopharm Group Co’s market cap?
    Sinopharm Group Co’s market cap is $7.40B.
      When is Sinopharm Group Co’s upcoming earnings report date?
      Sinopharm Group Co’s upcoming earnings report date is Oct 24, 2025 which is in 3 days.
        How were Sinopharm Group Co’s earnings last quarter?
        Sinopharm Group Co released its earnings results on Aug 22, 2025. The company reported $0.765 earnings per share for the quarter, beating the consensus estimate of N/A by $0.765.
          Is Sinopharm Group Co overvalued?
          According to Wall Street analysts Sinopharm Group Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Sinopharm Group Co pay dividends?
            Sinopharm Group Co pays a Annually dividend of $0.471 which represents an annual dividend yield of 4.01%. See more information on Sinopharm Group Co dividends here
              What is Sinopharm Group Co’s EPS estimate?
              Sinopharm Group Co’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Sinopharm Group Co have?
              Sinopharm Group Co has 268,362,150 shares outstanding.
                What happened to Sinopharm Group Co’s price movement after its last earnings report?
                Sinopharm Group Co reported an EPS of $0.765 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.715%.
                  Which hedge fund is a major shareholder of Sinopharm Group Co?
                  Currently, no hedge funds are holding shares in SHTDY

                  Sinopharm Group Co Stock Smart Score

                  Company Description

                  Sinopharm Group Co

                  Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

                  Sinopharm Group Co (SHTDY) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Cencora
                  Cardinal Health
                  Henry Schein
                  McKesson
                  Prestige Consumer Healthcare

                  Ownership Overview

                  <0.01%<0.01%100.00%
                  Insiders
                  <0.01% Other Institutional Investors
                  100.00% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis